贵阳什么医院治疗不孕不育贵阳妇科都包括哪些,贵阳怀孕流掉,贵阳有哪些不孕医院,贵阳不孕医院,贵阳引产医院去哪里,贵阳不孕医院哪家好,贵阳意外怀孕一个月怎么处理好

One COVID-19 vaccine in development may be ready for review in December.Executives at Novavax say they are enrolling volunteers for a second phase of clinical trials now. The data should be ready for review within a few months.Phase 1 data showed the two-dose vaccine in healthy adults produced antibodies in all participants. Tenderness and pain were the most frequent local symptoms.When the first COVID-19 vaccines are approved, we won't know a whole lot about their safety.“We’re going to learn as we go along. There are numerous case studies in our experience where, as vaccines were rolled out, we were quite confident with the safety profile, but that evolves,” said Dr. Jon Andrus, adjunct professor at George Washington University’s Milken Institute School of Public Health.“I think that these vaccines will be safe in the sense that they won’t cause a serious or permanent adverse event when tested in 10,000, 15,000, 20,000people,” said Dr. Paul A. Offit with the Children’s Hospital of Philadelphia. “Hopefully, that will also be true in post approval when it’s tested and seen in 20 million, 30 million people.”Based on other vaccine history, a COVID-19 vaccine will likely produce some sort of adverse reaction. It could be minor typical injection site issues or something more serious.Back in the 1950s, the very first massive polio vaccination program was stopped because it paralyzed some children and killed a handful.In the 70s, the swine flu vaccine caused a very small amount of rare neurological cases. There are other issues like an allergic reaction or seizure.Still though, experts say vaccines are one of the greatest advances in modern medicine in preventing unnecessary deaths.“There is no better cost-effective intervention that medical science has to offer with the exception of safe water and sanitation, so when you look at our life expectancy, vaccines have been incredibly important,” said Andrus.The Vaccine Injury Litigation Clinic handles cases of vaccine-related injuries and deaths. They have on average just over 600 people per year receive payouts from the National Vaccine Injury Compensation Program. But they admit vaccine injuries are still rare compared to the overall numbers of administered vaccines every year.The Centers for Disease Control and Prevention (CDC) says for every 1 million doses of vaccines that were distributed, one person was compensated. 2413

NYPD officers in Flatbush were allegedly saying “Trump 2020” over and over again on their patrol car’s speaker tonight.They stopped when someone started filming but couldn’t resist one more — in violation of the NYPD’s policy against endorsing candidates on duty. pic.twitter.com/BJMv4UCvnd— talia ‘stop filming faces’ jane (@itsa_talia) October 25, 2020 362

On Monday morning, Pfizer announced that so far in Phase 3 trials, its COVID-19 vaccine candidate has been 90% effective in promoting protection against the virus. And while the announcement has many Americans seeing the light at the end of the tunnel, the pandemic is still far from over.Pfizer's announcement on Monday is an encouraging sign, as it means that the company is on track to file for Emergency Use Authorization for the vaccine in the coming weeks. It also keeps the U.S. on a timeline to have at least one vaccine approved and available for distribution by the end of 2021.But Monday's announcement does not mean a vaccine is imminent. Pfizer is currently mass-manufacturing its vaccine candidate in the event it does receive Emergency Use Authorization from the FDA, and hopes to have 100 million doses of the vaccine ready to ship by year's end. But even if Pfizer is able to fulfill that ambitious order by Dec. 31, it would only be able to vaccinate about one-third of everyone in the county.Once the initial vaccine order has been completed, it will need to be rationed for those who need it most — likely health care workers, essential employees and people in high-risk populations. While it is unclear who exactly will be eligible to receive the vaccine first, the Department of Health and Human Services (HHS) says the early distribution of a COVID-19 vaccine will be "constrained tightly" and will be "highly targeted" to "achieve coverage in priority populations."Eventually, the U.S. hopes to grant emergency use authorization to several vaccine candidates — many of which are currently in production on orders from the U.S. government. HHS hopes that by the middle of next year, several vaccines will be approved and widely available. But at that point, officials will run into a second major hurdle — vaccine skepticism.Skepticism about vaccines has been on the rise in recent years, fueled in part by the spread of misinformation online. In particular, baseless conspiracies linking vaccines to autism have spread on social media, eroding public confidence in medicine. In addition, polarized politics in the U.S. have led to speculation that government leaders will approve an unsafe or ineffective vaccine for political purposes.Vaccines are only effective if enough members of the public become inoculated against a virus — if a virus has nowhere to spread, it will eventually die out. But Gallup polling released in October shows that just 50% of Americans say they would receive a COVID-19 vaccine if it had been approved by the FDA and available at no cost — far below the threshold for herd immunity, according to many health experts.The Gallup polling is consistent with AP polling from earlier this year that also only found 50% willingness to take a COVID-19 vaccine.All the while, the final push for a COVID-19 vaccine will be occurring during what members of the White House coronavirus task force warn will be the most concerning and deadly period of the pandemic. The virus is currently spreading in the U.S. faster than it has at any other point during the pandemic, just as Americans are moving social gatherings indoors where the virus is more likely to spread.To be clear, health officials' efforts to develop a safe and effective COVID-19 is a momentous and historic achievement — approving a vaccine for emergency use by the end of the year would shatter all previous records for vaccine development. But while there may be light at the end of the tunnel, it may take several months — or years — to reach the end of the pandemic. 3586

OCEANSIDE, Calif. (KGTV) - Police arrested a 37-year-old man in connection with the death of his 64-year-old mother, whose body was found in her Oceanside home. 168

OCEANSIDE, Calif. (KGTV) - The City of Oceanside has unveiled its latest effort to achieve their zero waste goals set back in 2011.Green Oceanside Kitchen is a state-of-the-art food recovery and preservation facility dedicated to eliminating waste and feeding the community."We need to do better, we need to feed our community and educate our community," said Colleen Foster, the City's Environmental Officer. The City teamed up with O'Side Kitchen Collaborative for the new project. They'll collect unwanted food from farmers, backyards, and food businesses, turning the goods into something delicious. "I could've done anything, but for me, making an impact in my community as well as it tasting good is the best!" said Vallie Gilley, Executive Director of O' side Kitchen Collaborative. The facility includes a 1,700 square foot commercial kitchen and a 500 square foot fridge that can hold about a semi-truck load of food. There's also an interactive demonstration kitchen for culinary arts training and education. Foster says more than 40 percent of what is grown and produced in the U.S. is wasted. With the new green facility, planners hope to save 20 percent of what would've gone to waste."That's thousands, if not hundreds of thousands, of pounds of food," said Foster. The facility was designed to maximize food recovery and preservation with specialty equipment installed throughout.Gillie's team will also be catering events to help support the program. 1475